Defilade Capital Management, L.P.
Position in ELAN — Elanco Animal Health Inc
CIK 2088557
EMERYVILLE, CA
Position in ELAN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,265,008
-$1,016,717 QoQ
Shares Held
864,080
-7.2% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
2.85%
of 13F equity value
Holder Rank
#68
of 518 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Defilade Capital Management, L.P. holds $35,982,530 across 2 Drug Manufacturers - Specialty & Generic names. ELAN ranks #1 (59.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
This page
|
864,080 | $21,265,008 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
132,662 | $14,717,522 |
All Filings in ELAN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,265,008 | 864,080 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,281,725 | 931,121 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $9,081,034 | 401,283 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||